Alexandre Passioukov

Vice President Translational Medicine at Pierre Fabre

Alexandre Passioukov leads translational medicine efforts across oncology, CNS and dermatology therapeutic areas at Pierre-Fabre R&D. Previously, Dr. Passioukov was leading translational medicine programs at Roche (Switzerland) with a special focus on immune-oncology drugs. Prior to joining Roche, Alexandre served as Head of Translational Research at EORTC in Brussels, conducting structural translational medicine activities of European clinical research networks.

Alexandre is MD with PhD in biology by Université Catholique de Louvain (UCL), where he was closely involved in the launch of 2 spin-off biotech companies: Coulter Pharma Belgium and Diatos.

Alexandre_Passioukov_BioTech_Pharma_Summit_Profile_Gut_Week_Microbiome_Skin_Brain_Dermatology_1

Case Study: Is human skin microbiota a goldmine for personalized diagnostic tests?

  • Personalized medicine - current state in different therapeutic areas: a real ‘patchwork’
  • Dermatology focus: potentials and principle hurdles for personalized diagnostics
  • Immediate challenges for leveraging skin microbiota data and ways out of it, role of AI

Other Speakers from the Gut Week Summit

Larry Weiss

CEO and Founder at Persona Biome

Éile Butler

Scientific officer at BioGaia

Huiying Li

Associate Professor at UCLA